Trial Profile
Retrospective study of adalimumab in hidradenitis suppurativa at Week 12
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 May 2018
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Hidradenitis suppurativa
- Focus Therapeutic Use
- 10 May 2018 New trial record